Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.

Subjects: CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/immunology ; CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/virology ; HIV Infections*/HIV Infections*/HIV Infections*/immunology

  • Source: The Journal of clinical investigation [J Clin Invest] 2024 May 01; Vol. 134 (9). Date of Electronic Publication: 2024 May 01.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1.

  • Authors : Whitehill GD; Department of Medicine, Division of Infectious Disease, and.; Joy J

Subjects: HIV-1*/HIV-1*/HIV-1*/immunology ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/immunology

  • Source: The Journal of clinical investigation [J Clin Invest] 2024 Apr 23; Vol. 134 (11). Date of Electronic Publication: 2024 Apr 23.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

HIV-1-infected T cell clones are shared across cerebrospinal fluid and blood during ART.

  • Authors : Wang M; Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, USA.; Yoon J

Subjects: HIV-1*/HIV-1*/HIV-1*/genetics ; HIV Infections*; Humans

  • Source: JCI insight [JCI Insight] 2024 Apr 08; Vol. 9 (7). Date of Electronic Publication: 2024 Apr 08.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

×
Academic Journal

Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control ; HIV-1*

  • Source: JCI insight [JCI Insight] 2024 Apr 08; Vol. 9 (7). Date of Electronic Publication: 2024 Apr 08.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

×
Academic Journal

The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.

  • Authors : Gasca-Capote C; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain.; Lian X

Subjects: HIV-1*/HIV-1*/HIV-1*/genetics ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy; Humans

  • Source: The Journal of clinical investigation [J Clin Invest] 2024 Feb 20; Vol. 134 (8). Date of Electronic Publication: 2024 Feb 20.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection.

Subjects: Cytomegalovirus Infections* ; HIV-1* ; HIV Infections*

  • Source: JCI insight [JCI Insight] 2024 Jan 16; Vol. 9 (4). Date of Electronic Publication: 2024 Jan 16.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

×
Academic Journal

Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo.

Subjects: HIV-1* ; Simian Acquired Immunodeficiency Syndrome* ; Simian Immunodeficiency Virus*

  • Source: JCI insight [JCI Insight] 2023 Nov 22; Vol. 8 (22). Date of Electronic Publication: 2023 Nov 22.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

×
Academic Journal

Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones.

Subjects: HIV-1* ; HIV Infections*; Humans

  • Source: The Journal of clinical investigation [J Clin Invest] 2023 Nov 01; Vol. 133 (21). Date of Electronic Publication: 2023 Nov 01.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.

  • Authors : McMyn NF; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Varriale J

Subjects: HIV-1* ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy; Humans

  • Source: The Journal of clinical investigation [J Clin Invest] 2023 Sep 01; Vol. 133 (17). Date of Electronic Publication: 2023 Sep 01.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
Academic Journal

Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model.

Subjects: Simian Acquired Immunodeficiency Syndrome* ; Simian Immunodeficiency Virus* ; Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/pharmacology

  • Source: The Journal of clinical investigation [J Clin Invest] 2023 Aug 15; Vol. 133 (16). Date of Electronic Publication: 2023 Aug 15.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

×
  • 1-10 of  339 results for ""HIV-1""